Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVOLOCUMAB vs OCRELIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EVOLOCUMAB vs OCRELIZUMAB: Safety Overview

Metric EVOLOCUMAB OCRELIZUMAB
Total FAERS Reports 149,666 56,186
Deaths Reported 1,723 1,406
Death Rate 1.2% 2.5%
Hospitalizations 6,890 10,364
Average Patient Age 68.1 yrs 47.2 yrs
% Female Patients 58.8% 72.5%
Manufacturer Amgen USA Inc. Genentech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription